Abiopharma

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

ESS Highlights Third-Party Utility Validating Iron Flow Battery Technology

BlockchAIn to Present at the 16th Annual LD Micro Invitational Conference on Tuesday, May 19, 2026

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

Publication date of reports for the first quarter of 2026 and a conference call on 20.5.26 in Hebrew at 10:00, in English at 15:00

Weatherford Wins Managed Pressure Drilling and Subsea Intervention Contracts with Constellation Oil Services in Offshore Brazil

Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia

MFS High Yield Municipal Trust Announces Preliminary Results of Tender Offer

Talkspace Expands U.S. Navy Mental Health Support for Sailors and Families